Coartem Dosing for a 9.4 kg Infant
For a 12-month-old male infant weighing 9.4 kg with uncomplicated malaria, administer Coartem 1 tablet per dose, given twice daily for 3 days (total of 6 doses over 3 days). 1
Dosing Schedule
The FDA-approved dosing for this weight category is straightforward:
- Weight band: 5 to <15 kg = 1 tablet per dose
- Regimen:
- Initial dose immediately
- Second dose 8 hours after the first dose
- Then twice daily (morning and evening) for the following 2 days
- Total: 6 doses over 3 days 1
Each tablet contains 20 mg artemether and 120 mg lumefantrine.
Critical Administration Requirements
Coartem MUST be taken with food to ensure adequate absorption, particularly of lumefantrine. 1 This is not optional—food significantly increases lumefantrine bioavailability, which is essential for treatment efficacy and preventing recrudescence.
For a 12-month-old infant who cannot swallow tablets whole:
- Crush the tablet and mix with 1-2 teaspoons of water immediately before administration 1
- Administer with fatty food or breast milk to optimize absorption
Evidence Supporting This Dosing
The 6-dose regimen has been extensively validated in African infants and children:
- Cure rates of 93-96% (PCR-corrected) in children weighing 5-25 kg 2
- The 6-dose regimen is significantly more efficacious than the older 4-dose regimen (96% vs 76% cure rate, P<0.0001) 2
- Safe and effective in non-immune infants weighing as little as 5 kg 2, 3
- Day 28 cure rates of 86.5% uncorrected and 93.9% PCR-corrected in African children 5-25 kg 3
Pharmacokinetic Considerations
At 9.4 kg, this infant falls within the validated weight band where:
- Artemether and lumefantrine exposures are comparable to adults when dosed on mg/kg basis 1
- The current weight-based dosing achieves therapeutic drug levels in children 5-15 kg 4
Recent research suggests potential underdosing concerns in some malnourished children 5, but the standard WHO-recommended regimen remains the evidence-based approach for routine clinical practice.
Safety Profile
The 6-dose regimen is equally well tolerated as the 4-dose regimen in children 2. Adverse events are typically mild, with no evidence of cardiotoxicity in pediatric studies 3. Treatment was well-tolerated even in infants <5 kg in recent trials 6.
Common Pitfalls to Avoid
- Do not skip the food requirement—this is the most common cause of treatment failure due to inadequate lumefantrine absorption
- Ensure all 6 doses are completed—stopping early dramatically reduces efficacy
- Do not adjust the dose based on precise weight calculations—use the weight band system as designed 1
- If the child vomits within 1-2 hours of a dose, repeat that dose